BLRX · BioLineRx Ltd.
$2.76
+0.04 (+1.52%)
At close · Aug 14
Market Cap
$12.42M
Shares
4.50M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-08 | — | |
| 6-K | 2026-05-27 | — | |
| 6-K | 2026-05-22 | — | |
| 6-K | 2026-05-19 | — | |
| 6-K | 2026-04-28 | — | |
| 6-K | 2026-03-26 | — | |
| 6-K | 2026-03-23 | — | |
| 20-F | 2026-03-23 | 2025-12-31 | |
| 6-K | 2026-02-23 | — | |
| 6-K | 2025-11-24 | — | |
| 6-K | 2025-11-17 | — | |
| 6-K | 2025-09-29 | — | |
| 6-K | 2025-08-14 | 2025-06-30 | |
| 6-K | 2025-06-30 | — | |
| 6-K | 2025-05-30 | — | |
| 6-K | 2025-05-27 | — | |
| 6-K | 2025-05-23 | — | |
| 6-K | 2025-03-31 | — | |
| 20-F | 2025-03-31 | 2024-12-31 | |
| 6-K | 2025-01-21 | — | |
| 6-K | 2025-01-17 | — | |
| 6-K | 2025-01-07 | — | |
| 6-K | 2025-01-06 | — | |
| 6-K | 2024-11-25 | — | |
| 6-K | 2024-11-21 | — | |
| 6-K | 2024-11-12 | — | |
| 6-K | 2024-11-05 | — | |
| 6-K | 2024-10-16 | — | |
| 6-K | 2024-10-01 | — | |
| 6-K | 2024-08-19 | — | |
| 6-K | 2024-08-15 | 2024-06-30 | |
| 6-K | 2024-06-18 | — | |
| 6-K | 2024-05-30 | — | |
| 6-K | 2024-05-28 | — | |
| 6-K | 2024-05-24 | — | |
| 6-K | 2024-05-17 | — | |
| 6-K | 2024-05-06 | — | |
| 6-K | 2024-04-17 | — | |
| 6-K | 2024-04-10 | — | |
| 6-K | 2024-04-01 | — | |
| 6-K | 2024-03-26 | — | |
| 20-F | 2024-03-26 | 2023-12-31 | |
| 6-K | 2024-03-04 | — | |
| 6-K | 2024-02-28 | — | |
| 6-K | 2024-02-16 | — | |
| 6-K | 2023-12-21 | — | |
| 6-K | 2023-12-12 | — | |
| 6-K | 2023-11-20 | — | |
| 6-K | 2023-10-12 | — | |
| 6-K | 2023-09-28 | — |
Showing 1–50 of 127 filings
Key facts
CIK
1498403
CUSIP
09071M304
13F (30d)
14 filings
14 filers
Visit website
Investor relations